They say when the U.S. sneezes, the whole world catches cold…

Well, it’s time for a trip to the drug store. More and more often, that means Central and Eastern Europe, or Emerging Europe.

For our Taipan VIP subscribers who attended our August Global Summit conference in San Francisco earlier this month, you may remember me mentioning a couple companies. Big names… Internationally recognized pharmaceutical companies like Teva Pharmaceuticals (TEVA:Nasdaq) and Sanofi-Aventis (SNY:NYSE). They’ve set up shop in places like Hungary and the Czech Republic.

Hungary is one of the most developed pharmaceutical and biotechnology sectors in Central and Eastern Europe. Hungary boasts the strongest biotech sector among the twelve new EU member states. That has enticed seventy core biotech companies to set up shop in Hungary up to now and 170 companies have some kinds of biotech related activities. The reason? Cost savings. Companies can save 30-50% compared to Western European enterprises.

But there’s another side to the drug industry and it’s increasingly finding a home in this very region.

Continue Reading »